Short CWTR@4.55

Current Mkt Cap of $420. Weak balance sheet with rBvE of $240. Should be discounted for illiquidity of cash assets and inventory ($72 and $166, respectively + total assets of 580M). No annual sales growth for past 4 years. No actual Income. What is the premium for then? Could be the 250M of accumulated depreciation--fair value of PPE actually greater than BV?

HOTT

Long @ $6.48

SKF

Long @ $18.69

Short the financial sector. Uncertainty about regulation and European banks.

GSL

Re-entered Long @ $2.89

PACR

Long @ $6.12 yesterday. High operational leverage and looks like it may return to profitability this year--good quarterly improvement over the past year. It gapped up today to open at $7.38 and is currently trading down - but more likely due to weak macroeconomic climate with Europe worries and banks possible adjustment of balance sheets.

HOTT added to watch list LONG today.

Potentially a new stock screener to use?

http://www.trade-ideas.com/StockInfo/_TopListResult.html?sort=MaxRV&MinVol30=5&MaxVol30=20&XN=on&X_NYSE=on&X_AMEX=on&show0=Price&show1=TV&show2=FCD

CFA

Break until exam is over!

DRYS

Long @ $6.35.

It's finally moving. I thought it was highly undervalued before - Lets see if it can break this week.

Still long GSL (shipping as well)

SSY

Short @ $3.9.

GSL

Bought @ $2.24 - should have waited for better pricing and not placed a market order...

Just an undervalued favorite of mine that I was waiting for a draw back for entry since I missed the original breakout!

WHRT

Shorted @$3.70 - borrowed shares too late and missed out on the $3.83 ask...

A Sykes-like short. Stock would not have been able to sustain the unusually high volume it had in it's run up from $2 to $4.5. The news of its medical device being used at University of Utah doesn't justify doubling the company's value. We'll have to see more use and an actual marketable revenue generating product before I''ll be buying -- could be a long time.

PUDA

Shorted@$8.82.

Tried shorting @$9.45 yesterday but there weren't any available shares! weak!

Overvalued. In it's most recent
earnings release, we see that for the year:

1) Operating income down about 30%
2) Unrealized Derivative Fair Value loss of $5.036 million
3) Net Income was down ~65%

Weak earning power and taking into account the rest of its assets and liabilities, it's overvalued and there's some downside.